Shares of Corcept Therapeutics Incorporated (:CORT) traded today at $25.43, eclipsing its 52-week high. This new high was reached on below average trading volume as 256,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares.
In the past 52 weeks, shares of Corcept Therapeutics Incorporated have traded between a low of $9.70 and a high of $25.43 and is now at $25.27, which is 161% above that low price.
Corcept Therapeutics Incorporated (:CORT) is currently priced 15.4% above its average consensus analyst price target of $21.37.
Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects…
Receive IBN Spotlights – “Bit Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN alerts, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer